日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

自体T细胞疗法治疗HLA-A*02+患者MAGE-A4+实体瘤:一项I期试验

David S Hong #,Brian A Van Tine #,Swethajit Biswas,Cheryl McAlpine,Melissa L Johnson,Anthony J Olszanski,Jeffrey M Clarke,Dejka Araujo,George R Blumenschein Jr,Partow Kebriaei,Quan Lin,Alex J Tipping,Joseph P Sanderson,Ruoxi Wang,Trupti Trivedi,Thejo Annareddy,Jane Bai,Stavros Rafail,Amy Sun,Lilliam Fernandes,Jean-Marc Navenot,Frederic D Bushman,John K Everett,Derin Karadeniz,Robyn Broad,Martin Isabelle,Revashnee Naidoo,Natalie Bath,Gareth Betts,Zohar Wolchinsky,Dzmitry G Batrakou,Erin Van Winkle,Erica Elefant,Armin Ghobadi,Amanda Cashen,Anne Grand'Maison,Philip McCarthy,Paula M Fracasso,Elliot Norry,Dennis Williams,Mihaela Druta,David A Liebner,Kunle Odunsi,Marcus O Butler

Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma

Tebentafusp,一种靶向gp100的TCR/抗CD3双特异性融合蛋白,可有效激活转移性黑色素瘤患者的抗肿瘤免疫反应。

Middleton, Mark R; McAlpine, Cheryl; Woodcock, Victoria K; Corrie, Pippa; Infante, Jeffrey R; Steven, Neil M; Evans, Thomas R Jeffry; Anthoney, Alan; Shoushtari, Alexander N; Hamid, Omid; Gupta, Avinash; Vardeu, Antonella; Leach, Emma; Naidoo, Revashnee; Stanhope, Sarah; Lewis, Sion; Hurst, Jacob; O'Kelly, Ita; Sznol, Mario